We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · May 04, 2021

One-Stop Nucleic Acid Sampling to Predict Nodal Positivity Following Neoadjuvant Chemotherapy

The Breast Journal

 

Additional Info

The Breast Journal
Can One Stop Nucleic Acid Sampling (OSNA) Predict Nodal Positivity Following Neoadjuvant Chemotherapy? A Prospective Cohort Study of 293 Patients
Breast J 2021 Apr 18;[EPub Ahead of Print], J Batt, T Schrire, Z Rayter

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading